Hematology/Oncology

Top Story

Cohort study finds 8% risk for secondary primary melanoma within 5 years

September 20, 2019
Meeting NewsPerspective

Breast cancer survivors who smoke, use hormones face higher lung cancer risk

September 20, 2019
BARCELONA — Use of hormone replacement therapy may increase risk for lung cancer as a second primary malignancy among patients with breast cancer who smoke…
Feature

Blood test could predict risk for breast cancer recurrence

September 20, 2019
Cytokine signaling responsiveness measured through a novel blood test may be a key determinant of intratumoral immunosuppressive potential and clinical outcome among…
Meeting NewsPerspective

Durvalumab reduces local, distant progression in non-small cell lung cancer

September 19, 2019
Durvalumab extended the time to first progression and reduced the risk for local and distant progression among patients with unresectable stage III non-small cell lung…
In the Journals

Palliative care linked to survival benefit in advanced lung cancer

September 19, 2019
Palliative care appeared associated with survival benefits among patients with advanced lung cancer, according to results of a retrospective study published in JAMA
More Headlines »
CME ABIM MOC

Ace the Case: A 54-year-old Man With 2 Weeks of Progressive Shortness of Breath

There is no commercial support for this activity.

This educational activity will utilize a case study to discuss the management of a 54-year-old man with 2 weeks of…
More »
Video
Meeting News

VIDEO: Astellas executive highlights key ASCO studies, company pipeline

June 27, 2019
More »
Resource Centers
Discoveries from ASCO: Breast Cancer

Discoveries from ASCO: Breast Cancer

CME

Updates in Genomic Testing for Breast Cancer: Rapid Response From Chicago

This activity is supported by an educational grant from Biotheranostics, Inc.

Multigene assays that evaluate an array of prognostic and/or predictive molecular markers have become critical for the…
More »
Current Issues
View the Current Issue
HemOnc Today Cell Therapy Next